molecular risk assessment
(muh-LEH-kyoo-ler risk uh-SES-ment)
A procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a person’s risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.